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microRNAthat non-protein-coding RNAs (ncRNAs) represent the majority of the human
transcripts. Regulatory role of many classes of ncRNAs is broadly recognized; however, long intronic ncRNAs
have received little attention. In the past few years, evidence that intronic regions are key sources of
regulatory ncRNAs has ﬁrst appeared. Here we present an updated vision of the intronic ncRNA world, giving
special attention to the long intronic ncRNAs. We summarize aspects of their expression pattern,
evolutionary constraints, biogenesis, and responsiveness to physiological stimuli, and postulate their
mechanisms of action. Deciphering nature's choice of different types of messages conveyed by ncRNAs will
shed light on the RNA-based layer of regulatory processes in eukaryotic cells.
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Recent improvements in high-throughput gene expression analysis
have led to the discovery that noncoding RNAs (ncRNAs) represent by
large the majority of the human transcriptional units [1–4]. UncoveringInstituto de Quimica, Departa-
200, 05508-000 São Paulo, SP,
a).
.
l rights reserved.this pervasive transcription has been followed by characterization of
manynovel functional regulatory ncRNAs, and therefore anupdate to the
deﬁnition of a gene and a review of themolecular biology central dogma
seems to be required [5,6]. Many classes of ncRNAs are now extensively
studied, and their regulatory role is broadly recognized. The miRNAs
represent a classical example of well-known ncRNA molecules that
perform regulation at the RNA level [7]. Other classes of short RNAs, such
as piRNA and snoRNA, have also attracted wide interest [8–10], and new
classes of short RNAs, such asXIST-derived RNAs (xiRNAs), are nowbeing
considered [11]. Likewise, long regulatory intergenic ncRNAs such as SRA
(SRA1) [12] andHOTAIR [13] have been characterized. On the other hand,
292 R. Louro et al. / Genomics 93 (2009) 291–298long ncRNAs transcribed from intronic regions have received less
attention from the scientiﬁc community, possibly due to the biased
perception that all of themmight result from immatureRNAs, aview that
is nowchanging, as discussed in the present review. Despite the fact that
there are a number of reviews concerning long ncRNAs regulating the
transcriptional machinery [14–17], none focuses on those transcribed
from introns.
In 2005, our group surveyed the main ﬁndings of the large-scale
expression analysis projects that led to the identiﬁcation of indepen-
dently transcribed intronic ncRNAs [18]. In most cases, information
about this class of ncRNAs was hidden among high-throughput
generated data, concerning different types of unknown transcripts.
Using in silico approaches based on genomic mapping and clustering
of ESTs, together withmicroarray experiments using combined intron/
exon oligoarrays we were able to point to intronic regions as key
sources of potentially regulatory ncRNAs [19,20]. The up-to-date
catalog of human and mouse intronic transcription described 78,147
and 39,660 long EST contigs, respectively, whose majority should
represent novel ncRNAs [20]. In addition, our work revealed that
about 81% and 70% of all spliced human and mouse protein-coding
genes, respectively, have transcriptionally active introns [20]. The last
few years were marked by functional characterization of some
interesting intronic ncRNAs, and it has been proposed that a number
of steps in the protein-coding RNA processing pathway may be
regulated by ncRNAs (Fig. 1), as detailed below. In the present review
we discuss the increasing knowledge about the intronic ncRNAworld.
Features of long intronic ncRNAs expressed from
mammalian genomes
Tissue-speciﬁc transcription and evolutionary conservation
Unbiased efforts that surveyed the human transcriptional output
have shown that novel unannotated transcripts, for which more than
30% reside within intronic regions, appear to be more tissue-speciﬁc
than well-characterized protein-coding RNAs [1,21]. In addition, two
recent papers focusing on intronic large-scale transcription have
reported similar results. Tissue-speciﬁc expression signatures of 1417
intronic ncRNAs were observed in prostate, kidney and liver, using a
gene-oriented combined intron/exon expression array platform [19].
Likewise, using in situ hybridization, 182 intronic ncRNAs were
associated with speciﬁc neuroanatomical regions, cell types, or
subcellular compartments of adult mouse brain [22].
Expression of ncRNAs seems to be under diverse levels of
evolutionary constraints in mammalians. In general, small ncRNAs
such as miRNAs seem to be highly conserved, while longer transcripts
are less conserved than typical exons [10,23]. Xist, responsible for
guiding X chromosome inactivation, and Air, involved in mouse
imprinted gene-silencing at the Igf2r locus, are examples of poorly
conserved long ncRNAs [23]. Probably the most extreme example that
shows lack of primary sequence conservation in long ncRNAs is HAR1
(HAR1A), part of a novel RNA gene that is expressed speciﬁcally in
Cajal–Retzius neurons in the developing human neocortex [24]. HAR1
is the acronym for “Human Accelerated Region 1”, and it was
identiﬁed as one genomic region that evolved rapidly in humans as
a result of a search for transcripts that were unique in human biology
[24]. In contrast, some long ncRNAs exhibit an unexpected high level
of nucleotide sequence conservation (N60%) in mammalians, such as
MALAT1 an intergenic long ncRNA involved in cancer and its murine
ortholog hepcarcin (Malat1) [25], and the Dnm3os intronic ncRNA,
differentially expressed during embryogenesis [26].
Recent reports have added other exciting evolutionary aspects to the
long intronic ncRNAs expression, using cross-species microarray
hybridization. A study on the expression of intergenic noncoding
sequences in human and chimpanzee showed tissue-speciﬁc conserva-
tion of expression of ncRNAs in equivalent genomic loci, but noconservation of the nucleotide sequences [27]. Similar results were
obtained for intronic sequences in humans andmice byour group. Using
a cross-speciesmicroarray hybridization approach,we identiﬁed a set of
22 long intronic ncRNAs, expressed from synthenic loci in humans and
mice. These long intronic ncRNAs showedverysimilarpatternsof tissue-
speciﬁc expression in both species in prostate, kidney or liver tissues
[20]. Surprisingly, these tissue-speciﬁc ncRNAs map to intronic regions
that have only short stretches of sequences with evidence of identity
conservation [20]. With an in silico approach, pyknons were recently
described, which by deﬁnition are recurrent motifs (N15 bases; N29
copies) present in intergenic and intronic regions with at least one
additional copy in an exonic region [28]. In both human and mouse
genomes pyknons were found to be over-represented in the introns of
protein-coding genes belonging to the same set of biological processes
and molecular functions, even though the underlying sequences were
not conserved between the two genomes [29]. Another report,
concerning 945 ncRNAs (338 intronic ncRNAs) expressed during
embryonic stem cell differentiation in mouse also contributed to
describe evolutionary constraints that govern ncRNAs expression [30].
The authors found that ncRNAs expressed during differentiation were
enriched for predicted RNA secondary structures relative to the genome
average [30]. In fact, more than 30,000 structured RNA elements had
already beenpredicted in the human genome, almost 1000 ofwhich are
conserved across all vertebrates; interestingly, a third of them are found
in introns of known genes [31].
These ﬁndings give additional support to the previous suggestion
that longer ncRNAs are under the inﬂuence of evolutionary constraints
different from those of miRNAs and snoRNAs, and that the lack of
primary sequence conservation does not necessarily signify an
absence of function [23]. Primary sequence conservation among
species might not be important for some cis acting mechanisms of
regulation, such as the case of transcriptional interference or
activation through transcription across regulatory regions [17].
Sequence conservation might be relevant for ncRNAs likely to work
in trans, when secondary structure is a requirement for these ncRNAs
to bind at RNA-binding protein targets in order to exert their cellular
functions. Recently, an intergenic ncRNA named HOTAIR has been
shown to bind to a polycomb group factor in order to regulate the
expression of homeobox genes [13], however no particular secondary
structure could be predicted in this case. A systematic search for
secondary structure conservation throughout the intronic ncRNA
dataset is warranted, and is likely to point to conserved motifs.
Expression in subcellular compartments
Alongside tissue speciﬁcity, intronic ncRNAs transcription seems to
be spatially restricted by subcellular expression preferences. Once
again, unbiased analyses have already indicated that a signiﬁcant
proportion of unannotated ncRNAs are exclusively detected in nuclear
or cytoplasmic cellular extracts [5,32]. Intronic ncRNAs expression
seems to be predominantly nuclear; however, some subsets were
primarily detected in the cytoplasm, and only a few seem to be equally
expressed in both compartments [33].
Responsiveness to physiological stimuli
To exert their functions on gene-expression control, it is expected
that intronic ncRNA expression would be responsive to physiological
stimuli. Indeed, cell line treatment with androgen hormone signiﬁ-
cantly alters the expression of a subset of intronic ncRNAs [34].
Similarly, exposure of two cell lines to retinoic acid altered the
expression of ncRNAs that lye downstream from intronic transcrip-
tion-factor binding sites for Sp1 (SP1), c-Myc (MYC) and p53 (TP53)
[35]. Either by direct activation [34], or indirectly via proteinic second
messengers [34,35], intronic ncRNA transcription responds to extra-
cellular environment modiﬁcations.
Fig.1. Schematic view of the genetic information ﬂow, highlighting the roles played by intronic non-protein-coding RNAs (ncRNAs). Thin arrows (red) represent regulation performed by intronic ncRNAs at different steps of the gene expression
pathway. Dark (red and blue) solid boxes and arrows represent constitutive exons of protein-coding transcripts. Solid (grey) boxes represent alternatively spliced exons. Introns are symbolized by light (red or blue) solid boxes. Independently
transcribed intronic ncRNAs are shown as dashed (red or blue) arrows. Black solid boxes represent promoter regions (PROM). Transcriptional direction is oriented by arrowheads. Proteins were drawn as roundish forms (red, blue or white).
RNAP — RNA polymerase. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Oncogenes and tumor suppressor genes such as N-myc (MYCN) and
p53 (TP53) were identiﬁed a long time ago as having ncRNAs
transcribed from their intronic regions [36,37], although a correlation
of these ncRNAs to cancer has not been studied. More recently,
aberrant expression of intronic ncRNAs has been correlated to cancer
development and progression. Expression signatures that distinguish
different degrees of neoplastic tissue differentiation in humanprostate
cancer included a signiﬁcant number of intronic ncRNAs [38]. Also in
renal cell carcinoma, an expression signature which includes intronic
ncRNAs allows discrimination between tumor and adjacent normal
tissues [39]. Experiments with whole-genome tiling arrays, searching
for long, conserved, abundantly expressed ncRNAs, revealed 15
transcripts whose expressionwas altered in breast and ovarian cancer;
at least three of themare intronic [40]. An intergenic long 8.6 kb ncRNA
named MALAT1 has been associated with metastasis in human lung
adenocarcinomas [41] andwas shown tobe overexpressed inﬁveother
types of human cancers [25]. It is now being recognized that long
intronic ncRNAs are cancer biomarkers [42], and further efforts are
underway in our group to use intronic ncRNA expression proﬁles to
foresee metastasis and tumor recurrence in different types of cancer.
Mechanisms of gene expression regulation by long
intronic ncRNAs
The widespread occurrence, tissue and subcellular expression
speciﬁcity, evolutionary conservation, environment alteration respon-
siveness and aberrant expression in human cancers are features that
accredit intronic ncRNAs to bemediators of gene expression regulation.Fig. 2. Postulated mechanisms of gene expression control by intronic ncRNAs at the trans
Epigenetic control of gene-expression through modulation of chromatin architecture. Dark
transcripts. Solid (grey) boxes represent alternatively spliced exons. Introns are symbolized by
dashed (red or blue) arrows. Black solid boxes represent promoter regions (PROM). Transcri
blue, white or grey). RNAP— RNA polymerase. HMT— histonemethyl transferase. (For interp
version of this article.)According to current knowledge, major control of gene expression
is mediated by protein-coding RNAs. A few large-scale studies showed
that certain sets of intronic ncRNAs have the same tissue expression
pattern as the corresponding protein-coding genes, whereas others
are inversely correlated [19,22,30,43]. These ﬁndings point to complex
regulatory relationships between intronic ncRNAs and their host loci.
It has been postulated that ncRNAs can act transcriptionally or post-
transcriptionally; however, mechanisms that underlie such regulatory
behaviors still remain to be fully understood. Below we discuss some
scenarios for gene expression regulation by long intronic ncRNAs.
Long intronic ncRNAs as precursors of shorter RNAs
It was initially thought that miRNAs are encoded mostly in
intergenic regions, however more recent data revealed that at least
one-fourth of mammalian miRNA loci are located within intron
regions and are transcribed by RNA polymerase II [44–46]. Some
snoRNAs also are encoded within intronic regions [9,47,48]. Interest-
ingly, a recent work showed that both human and mouse intronic
miRNAs tend to be present in large introns with 5′-biased position
distribution [48], what correlates with the previous observation that
most long intronic transcripts are expressed within ﬁrst introns of the
host genes [19]. The 5′-biased positions of miRNA host introns may be
necessary for the transcription and regulation of intronic miRNAs to
utilize the regulatory signals within the 5′-UTRs of their host genes
[48]. We expect that a number of long intronic ncRNAs are processed
into smaller ncRNAs to exert their cellular functions, according to
previously described mechanisms [7,9].
In this regard, a recent report opens a possible new perspective
for functional studies of long ncRNAs [49]. This study described a verycriptional level. (A) Transcriptional interference through interaction at promoters. (B)
(red and blue) solid boxes and arrows represent constitutive exons of protein-coding
light (red or blue) solid boxes. Independently transcribed intronic ncRNAs are shown as
ptional direction is oriented by arrowheads. Proteins are drawn as roundish forms (red,
retation of the references to colour in this ﬁgure legend, the reader is referred to the web
Fig. 3. Postulated mechanisms of gene expression control by intronic ncRNAs at post-
transcriptional level. (A) Regulation of protein-coding RNA alternative splicing. (B)
Protein-coding RNA stabilization. Dark (red) solid boxes and arrows represent
constitutive exons of protein-coding transcripts. Solid (grey) boxes represent
alternatively spliced exons, and light (red) boxes represent introns. Independently
transcribed intronic ncRNAs are shown as dashed (red) arrows. Transcriptional
direction is oriented by arrowheads. (For interpretation of the references to colour in
this ﬁgure legend, the reader is referred to the web version of this article.)
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(CDKN2B) genomic locus (p15AS), spanning the intronic region [49].
In this work the authors proved that just a fragment of p15AS that
overlaps the ﬁrst exon of p15 protein-coding gene is sufﬁcient to
control its chromatin architecture [49]. We envisage that functional
studies similar to that described for p15AS [49] can be conducted by
overexpression of only a portion of other long ncRNAs in analysis,
irrespective of the fact that a shorter ncRNA is or is not endogenously
produced in a cell. However, it remains to be determined if the effects
observed when using just a fragment of the ncRNA [49] are similar to
those exerted by the full-length ncRNAs, and which regions are
essential to their functions. In this context, it should be noted that
Dicer (DICER1) was not required for the antisense ncRNA to exert its
regulatory function [49].
Interaction of ncRNAs with promoter elements and transcription factors
Intronic sense and antisense ncRNAs may repress a neighboring
protein-coding gene through a phenomenon termed transcriptional
interference (Fig. 2A), which prevents initiation complex recruitment
or transcriptional elongation [50]. In humans, there is evidence that a
partially intronic ncRNA, produced from the genomic locus encoding
dihydrofolate reductase (DHFR), directly interacts with the major
promoter, decreasing the expression of the protein-coding RNA [51].
Another recent work showed that long spliced antisense transcripts,
overlapping the promoter of the progesterone receptor gene (PGR), are
necessary for activation of PGR expression [52]. Small duplex RNAs,
called antigene RNAs, are complementary to promoter sequences and
could activate or repress gene expression, probably through binding
these long spliced antisense transcripts [52,53]. It seems that some
endogenous miRNAs are also complementary to promoters and,
therefore, could be involved in these mechanisms [52].
Several reports have suggested a model in which ncRNAs could
function asmolecular adaptors, providing increased speciﬁcity in gene
expression control by guiding the RNA/DNA-binding proteins to
promoter regions. The DHFR protein-coding RNA repression involves
not only the formation of a stable complex between ncRNA and the
major promoter, but it is also accompanied bya direct interaction of the
ncRNAwith the general transcription factor IIB and the dissociation of
the pre-initiation complex from the major promoter [51]. Another
example is the gene-speciﬁc repression of cyclin D1 (CCND1) in human
cell lines, caused by recruitment of the translocated in liposarcoma
(TLS) RNA-binding protein (FUS). The TLS protein is directed to the
CCND1 promoter by long (N200 nt) ncRNAs, and tethered to its 5′
regulatory region in response to DNA damage signals [54].
Interestingly, taking the full repertoire of human long ncRNAs, a
higher proportion of transcripts are mapped to the ﬁrst introns of
protein-coding genes [19,33], a region relatively close to the promoter.
They could act through DHFR-like mechanisms [51], or be precursors
of promoter-complementary miRNAs [52].
Epigenetic control of gene expression
Only lately modiﬁcations on the chromatin architecture that
regulate gene expression – epigenetic regulation – have been linked
to ncRNAs (Fig. 2B). The most prominent examples involving ncRNAs
include the trimethylation of histone H3 on lysine 27 by Polycomb
group proteins (PcG). Transcription of intergenic XIST ncRNA from one
of the two female X chromosomes is involved in recruiting PcG to
normalize the copy number of X chromosomes between male and
female cells [55]. Likewise, the expression of homeobox genes that
encode key development regulators in the embryo could be repressed
by an RNA–protein complex of intergenic HOTAIR ncRNA and PcG
repressive complex 2 [13].
However, to our knowledge, until now there is only one
description of a naturally occurring long intronic ncRNA that acts asan epigenetic modiﬁer. Endogenous long antisense ncRNA KHPS1 is
originated from the CpG island of sphingosine kinase-1 gene (SPHK1),
and it overlaps a sense regulatory element named tissue-dependent
differentially methylated region (T-DMR) [56]. Overexpression of two
KHPS1 fragments caused DNA demethylation of T-DMR. Intriguingly,
this intronic transcript is also transported to the cytoplasm, suggesting
that the same transcript could be involved in the post-transcriptional
regulation mechanisms [56].
Regulation of protein-coding RNA alternative splicing
Control of alternative pre-mRNA splicing is another layer of gene
expression regulation to which intronic ncRNAs are demonstrated to
be related (Fig. 3A). About two decades ago, it had already been
recognized that an antisense RNA, transcribed from the ﬁrst intron of
N-myc genomic locus, could modulate RNA splicing by forming RNA–
RNA duplexes and preserving a population of N-myc mRNA retaining
intron 1 [36]. More recently, it was shown that overexpression of SAF,
a 1.500 nt partially intronic ncRNA, transcribed from the opposite
strand of intron 1 of the human FAS gene, caused functionally
important alterations in FAS alternative splicing [57]. Expression of
SAF ncRNA did modulate the expression of different Fas protein
soluble forms, making cells more resistant to Fas-mediated apoptosis
[57].
Alternative splicing events must be strictly regulated to properly
encode diverse, but functional proteins [58], and the average
frequency of exon-skipping for exons overlapped by or located
immediately 3′ to the intronic ncRNAs is higher than the average
frequency of exon-skipping in the overall set of human RefSeq RNAs
296 R. Louro et al. / Genomics 93 (2009) 291–298[19]; it is tempting to speculate that this sort of regulatory relation is
probably more common than anticipated.
Protein-coding RNA stabilization
Anotherpossibilityof control byncRNAs is that intronic ncRNAs could
play their regulatory roles via stabilization of protein-coding RNA,
transcribed from the same genomic loci (Fig. 3B). Many unstable
mammalian protein-coding RNAs contain adenylate- and uridylate-rich
(AU-rich) elements that determine their half-life [59]. In B-cell
lymphomas that exhibit the 14;18 chromosome translocation, a bc1-2/
IgH antisense ncRNAcontributes to the upregulation of bcl-2 (BCL2) gene
expression, probably bymasking AU-richmotifs present in the 3′UTR of
the bcl-2 protein-codingRNA [59]. Although nodirect evidence has been
obtained for the involvementof naturally occurring long intronic ncRNAs
in such a mechanism, the concordant expression proﬁles between
protein-coding and intronic ncRNAs, observed in genome-wide expres-
sion analysis, suggest that a gene expression control by protein-coding
RNA stabilization is plausible in normal cells [19,30,34,35].
Global gene expression regulation by trans-acting control
Mechanisms of gene expression regulation by intronic ncRNAs,
previously discussed, are illustrated through examples related to
locus-speciﬁc regulation. However, introns of protein-coding genes
were postulated to contain signals that could contribute to the
complexity of gene expression regulation networks [60]. ncRNAs fulﬁll
the essential conditions for being system connectivity and multi-
tasking agents, and this could allow them to be control molecules that
mediates gene–gene communication [61]. Only recently some
experimental evidence of these early conjectures was reported.
Hill et al. [62] demonstrated that complete human introns are
capable of coordinating expression of functionally related genes. They
overexpressed three long intronic sequences from the cystic ﬁbrosis
transmembrane conductance regulator (CFTR) gene in epithelial cells
(HeLa), in which CFTR is not normally expressed. Surprisingly, they
observed that the expression of the CFTR introns caused extensive and
speciﬁc transcriptional changes, affecting mainly genes linked to CFTR
function. Affected genes were distributed at spatially diverse sites
within the genome. Each of three intronic sequences induced unique
and highly reproducible changes in gene expression proﬁle. Since
these transfected cells do not express the CFTR protein-coding
transcript, observed effects were certainly caused by the intronic
sequences. Because all three intronic sequences do not include any
knownmiRNAs or predicted stem–loop structures, they seem to act in
trans as long ncRNA regulatory elements. In conclusion, Hill et al. [62]
reported the ﬁrst evidence that long intronic sequences could
coordinate waves of gene expression important for particular cellular
processes, functionally related to the protein-coding transcript of the
same locus.
Interestingly, a recent work showed that intron-derived miRNA
also could be involved in a similar type of control, silencing a cohort of
genes that are functionally antagonistic to the host gene itself [63].
Transcriptional activation of apoptosis-associated tyrosine kinase
(AATK), essential for neuronal differentiation, also generates intronic
miR-338 that silences a family of mRNAs, related to the negative
regulation of neuronal differentiation [63].
The fact that even non-degraded spliced introns can be selectively
exported to the cytoplasm [64] and be involved in global gene
expression regulation [62] makes even more intriguing the question
about the function of independently transcribed intronic sequences.
Long intronic ncRNAs, or shorter RNAs originated from the former,
could regulate global gene expression using mechanisms previously
described for mammalian ncRNAs, such as binding to promoters and
transcription factors [51], recruiting of Polycomb Repressive Complex
2 [13] or other RNA-binding proteins [12,54]. Interestingly, many ofthese mechanisms are associated with transcription repression. A
large number of genes up-regulated after overexpression of intronic
sequences [62] could be explained by both guiding activation factors
and indirect targeting through inhibition of suppressors.
Long intronic ncRNA biogenesis
The biogenesis of long intronic ncRNA is poorly understood. An
ample involvement of RNA polymerase II (RNAP II) on the transcrip-
tion of ncRNAs has been presumed because of indirect evidence such
as (1) concordant and co-regulated expression proﬁles of many
intronic ncRNAs and their corresponding protein-coding genes
[19,30,34,35]; (2) the presence of poly(A+) tail [2,3,5,19,21]; and also
(3) the broad contribution of RNAP II-associated transcription factors
and physiological stimuli in the transcription of intronic ncRNAs
[34,35]. Such observations do not completely exclude the possibility
that some intronic transcripts could represent unexpectedly long-
lasting lariats that could be processed post-splicing as well.
Long intronic ncRNAs have been extensively identiﬁed in poly(A+)
RNA populations [2,3,5,19,21] by using approaches that assume the
RNAP II-transcript poly(A) tail occurrence, such as oligo-d(T)-primed
reverse transcription. The difﬁculties to perform large-scale measure-
ments of poly(A−) ncRNA expression add a bias towards the detection
of poly(A+) intronic ncRNAs; nevertheless, poly(A−) RNAs seem to
represent an important fraction of human transcriptional output
[5,32], and large-scale sequencing of the poly(A−) RNA fraction [32]
will probably open the door for exploring the pattern of expression of
this class of RNAs.
Enhancing the complexity of this picture, our group has reported
that over 10% of long intronic poly(A+) ncRNAs are up-regulated after
treatment with the RNAP II speciﬁc inhibitor α-amanitin [19],
whereas only 4% of protein-coding transcripts are up-regulated
under the same conditions [19,65]. These ﬁndings suggest that some
intronic ncRNA and peculiar protein-coding RNAs could be transcribed
by another RNA polymerase such as the recently described spRNAP-IV,
whose transcriptional output seems to be enhanced by α-amanitin
[65], or also could be transcribed by RNAP III [46,66]. Nonetheless, α-
amanitin cell treatment also evokedmRNA accumulation of somewell
studied RNAP II transcribed protein-coding genes, such as p53 [67]
and TNF-alpha (TNF) [68]. A report demonstrated that treatment with
α-amanitin could inﬂuence phosphorylation of RNAP II CTD (C-
terminal domain) and, through this, induce enhanced elongation of
some protein-coding transcripts [69]. This suggests that the pre-
viously cited results of apparent up-regulation of noncoding and
protein-coding RNAs could represent a less explored effect of α-
amanitin on RNAP II transcription elongation.
Interestingly, two in silico identiﬁed totally intronic ncRNAs (TIN
52044 and 52045) [19] map to a very long (∼35,000 nt) recently
described antisense ncRNA that encompasses the entire p15 genomic
locus (p15AS) [49]. Such observation means that the present level of
coverage of intronic ncRNA transcription probably results in partial
identiﬁcation of many longer messages. Undoubtedly, further studies
are warranted to characterize full-length intronic messages and
convincingly unveil the biogenesis of long intronic ncRNAs. Systematic
search for the presence of characteristic RNAP II-derived attributes in
long intronic ncRNAs, a deeper study of poly(A−) RNA populations and
the investigation of possible involvement of other polymerases could
provide new information that would certainly clarify this subject.
Could it be merely an artifact?
Experimental artifacts have been widely discussed as the main
contributors in the detection of pervasive intronic transcription. The
most commented are contamination of RNA samples with residual
genomic DNA (gDNA) or immature unspliced RNAs [4], and annealing
of oligo-dT primers to poly(A) repeats instead of to poly(A) tails [70].
297R. Louro et al. / Genomics 93 (2009) 291–298In fact, even abundant DNase treatment is not sufﬁcient for
complete elimination of contaminant gDNA [4,71]. Controls for gDNA
contamination, omitting reverse transcription step, arewidely applied
for checking sample quality [4,34,38,72]. Even in samples having
residual gDNA contamination, mispriming with oligo-dT from
adenine-rich DNA regions is not so common due to the fact that the
RNA-dependent DNA-polymerase activity of reverse transcriptase is
more efﬁcient than the DNA-dependent one [73]. However, misprim-
ing could occur to adenine-rich regions of RNA transcripts, producing
a cluster of multiple, shorter cDNAs from longer parental transcripts
[74]. Mispriming of RNA evokes the problem of full-length transcript
characterization, but is not a source of false positives.
Many groups have detected intronic ncRNAs in the cytoplasmic
fraction [5,21,22,33] whose contamination with gDNA and unprocessed
mRNA should be minimal. A number of loci show discordant expression
proﬁles between ncRNAs and their associated protein-coding genes
[19,22]. Even in cases with apparently concordant expression proﬁles,
sense and antisense transcriptsmaynot beexpressed in the exactly same
cell or may have different compartmentalization [75]. In addition, many
long ncRNAs were conﬁrmed by Northern blot [34,36–38,40,57]. Finally,
all the speciﬁc features of ncRNA expression, discussed previously, make
it improbable that detection of ncRNAs is an artifact originated by
random contaminationwith gDNA, immature transcripts ormispriming.
The early suggestions about participation of intronic sequences in
the regulation of gene expression have considered as the main actors
the stable intronic sequences derived from pre-mRNAs [60,61], but no
independently transcribed products. Currently, there is evidence of
independent promoters and transcription factor binding sites within
intronic sequences [35,76,77]; nonetheless, so far no particular
intronic ncRNA promoter has been characterized in detail. At this
point, one cannot exclude the possibility that intronic RNAs, processed
post-splicing, also participate in RNA-mediated transactions within
the cell [61]. Concordant expression proﬁles for the majority of
intronic ncRNA-protein-coding mRNA pairs [19,22] indicate that at
least some of them could be processed from the same pre-mRNA.
However, because these ncRNAs are stable and most likely functional,
one cannot consider themmerely artifacts from unprocessed RNA, but
rather intronic ncRNAs produced from a common protein-coding RNA
precursor (Fig. 1).
Conclusions and perspectives
Studies of gene expression in eukaryotes have begun to rediscover
the RNA world and its direct relation with structural, physiological,
and behavioral complexity of organisms. As listed above, recent
studies have provided signiﬁcant contributions to the characterization
of intronic ncRNAs as the largest portion of the human genome
transcriptional units, pointed to mechanisms of action during gene
expression control and investigated aspects of their biogenesis and
responsiveness to physiological stimuli. Such gain of knowledgemight
provide answers to the molecular basis of eukaryotic complex
attributes, which do not seem to rely solely on the number of
expressed proteins.
The present scenario argues that evolutionary complexity should
be a matter of novel and complex interactions using relatively few and
fairly similar proteinic components, whose expression is temporally
and spatially controlled by ncRNA networks. Until recently, the
complexity level of the genetic programming in higher organisms
was underestimated, merely pointing to proteins as the regulatory
players of gene expression. An updated view of the molecular biology
central dogma seems to be in order, highlighting the role of an RNA-
based layer of regulation, and summarizing the possible mechanisms
of action of intronic ncRNAs. It is envisaged that a deeper transcript
sequencing of different cell and tissue types under physiological and
pathological conditions using the next-generation sequencers will
probably reveal in the near future the wide diversity and the peculiarspeciﬁcities of the human transcriptome. Deciphering nature's choice
of different types of messages, conveyed by these ncRNAs, through the
identiﬁcation of their most relevant expression patterns and mechan-
isms of action, is the greatest challenge lying ahead of us.
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